🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 19 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 08/10/1985 | 2,87 | 2,91 | 2,86 | 2,91 | +1,39% | 1,62% | 5.738.429 |
| 07/10/1985 | 2,84 | 2,89 | 2,82 | 2,87 | +1,53% | 2,45% | 8.036.064 |
| 04/10/1985 | 2,82 | 2,83 | 2,81 | 2,83 | +0,12% | 0,59% | 3.006.922 |
| 03/10/1985 | 2,83 | 2,84 | 2,81 | 2,82 | -0,47% | 1,17% | 10.024.330 |
| 02/10/1985 | 2,89 | 2,89 | 2,84 | 2,84 | -1,61% | 1,95% | 10.650.614 |
| 01/10/1985 | 2,87 | 2,89 | 2,85 | 2,88 | +0,46% | 1,50% | 6.772.176 |
| 30/09/1985 | 2,88 | 2,89 | 2,86 | 2,87 | -0,58% | 0,92% | 4.625.453 |
| 26/09/1985 | 2,86 | 2,89 | 2,86 | 2,89 | +0,69% | 0,81% | 5.553.562 |
| 25/09/1985 | 2,90 | 2,90 | 2,86 | 2,87 | -1,26% | 1,37% | 10.726.070 |
| 24/09/1985 | 2,90 | 2,94 | 2,90 | 2,90 | +0,23% | 1,37% | 9.643.277 |
| 23/09/1985 | 2,90 | 2,91 | 2,89 | 2,90 | +1,16% | 0,69% | 9.643.277 |
| 20/09/1985 | 2,87 | 2,89 | 2,86 | 2,86 | -0,58% | 1,04% | 7.937.971 |
| 19/09/1985 | 2,85 | 2,89 | 2,85 | 2,88 | +0,70% | 1,40% | 10.186.560 |
| 18/09/1985 | 2,92 | 2,92 | 2,74 | 2,86 | -2,60% | 6,12% | 42.481.728 |
| 17/09/1985 | 2,95 | 2,96 | 2,94 | 2,94 | -0,56% | 0,79% | 12.276.691 |
| 16/09/1985 | 2,95 | 2,97 | 2,95 | 2,95 | +0,12% | 0,79% | 3.025.786 |
| 13/09/1985 | 2,96 | 2,98 | 2,94 | 2,95 | -0,67% | 1,12% | 6.387.350 |
| 12/09/1985 | 2,98 | 2,98 | 2,96 | 2,97 | -0,11% | 0,67% | 5.447.923 |
| 11/09/1985 | 3,01 | 3,01 | 2,97 | 2,97 | -0,88% | 1,21% | 8.922.672 |
| 10/09/1985 | 3,01 | 3,02 | 3,00 | 3,00 | -0,66% | 0,66% | 2.935.238 |
| 09/09/1985 | 3,01 | 3,02 | 3,01 | 3,02 | +0,33% | 0,44% | 1.916.582 |
| 06/09/1985 | 3,01 | 3,02 | 3,01 | 3,01 | -0,11% | 0,55% | 3.976.531 |
| 05/09/1985 | 3,02 | 3,02 | 3,01 | 3,01 | -0,22% | 0,33% | 3.105.014 |
| 04/09/1985 | 3,02 | 3,02 | 3,01 | 3,02 | -0,11% | 0,44% | 2.267.453 |
| 03/09/1985 | 3,02 | 3,02 | 3,01 | 3,02 | -0,11% | 0,33% | 3.138.970 |
| 30/08/1985 | 3,02 | 3,05 | 3,01 | 3,02 | -0,76% | 1,20% | 2.844.691 |
| 29/08/1985 | 3,06 | 3,07 | 3,05 | 3,05 | -0,76% | 0,65% | 4.802.774 |
| 28/08/1985 | 3,05 | 3,07 | 3,05 | 3,07 | +0,43% | 0,76% | 2.995.603 |
| 27/08/1985 | 3,06 | 3,06 | 3,05 | 3,06 | +0,11% | 0,43% | 11.069.395 |
| 26/08/1985 | 3,09 | 3,09 | 3,05 | 3,05 | -1,49% | 1,28% | 4.538.678 |